Walleye Capital LLC Spring Works Therapeutics, Inc. Transaction History
Walleye Capital LLC
- $38.9 Billion
- Q4 2024
A detailed history of Walleye Capital LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 1,200 shares of SWTX stock, worth $59,808. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,200
Previous 286,093
99.58%
Holding current value
$59,808
Previous $9.17 Million
99.53%
% of portfolio
0.0%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding SWTX
# of Institutions
236Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$357 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$280 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$172 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$163 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$150 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.11B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...